GE Vernova T&D India Q3 profit jumps over 100% to ₹291 crore on strong revenue, margins, and robust orders.

GE Vernova T&D India reported a strong performance for the third quarter ended December 31, 2025, with net profit rising sharply to ₹290.8 crore from ₹142.7 crore in the year-ago period.

Revenue surged

58.4% year-on-year to ₹1,700 crore from ₹1,073 crore, supported by healthy project execution and a robust order pipeline.

EBITDA more than doubled to ₹290.8 crore from ₹142.7 crore a year ago, while operating margin expanded significantly to 26.7% from 16.7% last year.

Order bookings during the quarter stood at ₹294 crore, up 41% from ₹208 crore in the same quarter last year, driven by robust demand across the transmission and distribution segment.

The company made an additional provision of ₹6.93 crore in the quarter and for the nine months ended December 31, 2025, to account for the estimated financial impact of the four labour codes notified by the Government of India.

As per the exchange filing, the company also adopted hedge accounting under Ind AS 109 for certain highly probable forecast transactions, resulting in a recognised loss of ₹1.39 crore for the current quarter, ₹20.97 crore for the nine months ended December 31, 2025, and ₹2.68 crore for the financial year ended March 31, 2025.

Commenting on the performance, Sandeep Zanzaria, Managing Director & CEO of GE Vernova T&D India Limited, said, “Our strong Q3 performance reflects India's fast-paced energy transformation, driven by record renewable capacity additions that are reshaping the nation's power landscape. As renewables increase in India's energy mix, the demand for robust transmission and distribution infrastructure has never been greater to ensure grid stability and reliability. We remain committed to our disciplined approach of pursuing margin-accretive orders that deliver sustainable value, positioning us to capitalise on India's long-term energy transition while maintaining operational excellence.”

Shares of GE Vernova T&D India ended higher on Wednesday, January 28, by 6.59% at ₹2,911.00 on the NSE.

Also Read: Star Health Q3 profit falls 40% as underwriting losses bite, premiums still grow